Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
about
Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers.Simultaneous MR quantification of hepatic fat content, fatty acid composition, transverse relaxation time and magnetic susceptibility for the diagnosis of non-alcoholic steatohepatitis.
P2860
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
@en
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
@nl
type
label
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
@en
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
@nl
prefLabel
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
@en
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
@nl
P2093
P2860
P356
P1476
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
@en
P2093
Ahmed Ba-Ssalamah
Andreas Wibmer
Christian J Herold
Jacqueline C Hodge
Michael Trauner
Mustafa R Bashir
Nina Bastati
Romana Fragner
P2860
P304
P356
10.1002/JMRI.25518
P577
2016-11-08T00:00:00Z